Does tyrosyl DNA phosphodiesterase-2 play a role in hepatitis B virus genome repair?

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Cui, Xiuji ^a   McAllister, Rebecca ^a   Boregowda, Rajeev ^a,e   Sohn, Ji A ^b   Ledesma, Felipe Cortes ^c   Caldecott, Keith W ^d   Seeger, Christoph ^b   Hu, Jianming ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; ENZYME; RNA DIRECTED DNA POLYMERASE; TYROSYL DNA PHOSPHODIESTERASE 2; UNCLASSIFIED DRUG; VIRUS RNA; NUCLEAR PROTEIN; TDP2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; VIRAL PROTEIN; VIRUS DNA;

ARTICLE; CHRONIC HEPATITIS B; CONTROLLED STUDY; COVALENT BOND; DNA CLEAVAGE; DNA SYNTHESIS; DUCK HEPATITIS B VIRUS; GENE AMPLIFICATION; GENE INACTIVATION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PERSISTENT VIRUS INFECTION; VIRION; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; GENE SILENCING; GENETICS; HEP-G2 CELL LINE; HEPATITIS B; METABOLISM; PHYSIOLOGY; UPREGULATION;

DUCK HEPATITIS B VIRUS; HEPATITIS B VIRUS;

DNA, CIRCULAR; DNA, VIRAL; GENE KNOCKDOWN TECHNIQUES; GENE KNOCKOUT TECHNIQUES; GENOME, VIRAL; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS, DUCK; HEPATITIS VIRUS, DUCK; HUMANS; NUCLEAR PROTEINS; RNA-DIRECTED DNA POLYMERASE; TRANSCRIPTION FACTORS; UP-REGULATION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84937889320     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128401     Document Type: Article

References (41)

1. Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014. doi: 10.1016/S0140-6736(14) 60220-8 PMID: 24954675.
2. Seeger C, Zoulim F, Mason WS. Hepadnaviruses. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott, Williams & Wilkins; 2013. p. 2185-221.
3. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 1982; 29(2):403-15. PMID: 6180831
4. Hu J, Seeger C. Hepadnavirus Genome Replication and Persistence. In: Seeger C, Locarnini S, editors. Cold Spring Harb Perspect Med: Cold Spring Harbor Laboratory Press; 2015.
5. Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 1986; 47(3):451-60. PMID: 3768961.
6. Wang GH, Seeger C. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell. 1992; 71(4):663-70. PMID: 1384989
7. Weber M, Bronsema V, Bartos H, Bosserhoff A, Bartenschlager R, Schaller H. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J Virol. 1994; 68(5):2994-9. PMID: 7512155
8. Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol. 1994; 68(1):6-13. PMID: 7504742
9. Jones SA, Boregowda R, Spratt TE, Hu J. In vitro Epsilon RNA-Dependent Protein Priming Activity of Human Hepatitis B Virus Polymerase. J Virol. 2012; 86(9):5134-50. Epub 2012/03/02. doi: 10.1128/jvi. 07137-11 PMID: 22379076.
10. Wu TT, Coates L, Aldrich CE, Summers J, Mason WS. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology. 1990; 175 (1):255-61. PMID: 2155510
11. Gao W, Hu J. Formation of Hepatitis B Virus Covalently Closed Circular DNA: Removal of Genome- Linked Protein. J Virol. 2007; 81(12):6164-74. PMID: 17409153.
12. Zhang YY, Zhang BH, Theele D, Litwin S, Toll E, Summers J. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(21):12372-7. PMID: 14528003.
13. Litwin S, Toll E, Jilbert AR, Mason WS. The competing roles of virus replication and hepatocyte death rates in the emergence of drug-resistant mutants: theoretical considerations. J Clin Virol. 2005; 34 Suppl 1:S96-S107. PMID: 16461233.
14. Guo H, Jiang D, Zhou T, Cuconati A, Block TM, Guo JT. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol. 2007; 81(22):12472-84. PMID: 17804499.
15. Raney AK, Eggers CM, Kline EF, Guidotti LG, Pontoglio M, Yaniv M, et al. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol. 2001; 75(6):2900-11. PMID: 11222715
16. Hantz O, Parent R, Durantel D, Gripon P, Guguen-Guillouzo C, Zoulim F. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol. 2009; 90(Pt 1):127-35. PMID: 19088281.
17. Summers J, Smith PM, Horwich AL. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol. 1990; 64(6):2819-24. PMID: 2335817
18. Summers J, Smith PM, Huang MJ, Yu MS. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J Virol. 1991; 65(3):1310-7. PMID: 1995945
19. Lentz TB, Loeb DD. Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus. J Virol. 2011; 85 (22):11916-27. Epub 2011/09/09. JVI.05373-11 [pii] doi: 10.1128/JVI.05373-11 PMID: 21900164; PubMed Central PMCID: PMC3209309.
20. Cortes Ledesma F, El Khamisy SF, Zuma MC, Osborn K, Caldecott KW. A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature. 2009; 461(7264):674-8. PMID: 19794497. doi: 10.1038/nature08444
21. Zeng Z, Cortes-Ledesma F, El Khamisy SF, Caldecott KW. TDP2/TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase IIinduced DNA damage. The Journal of biological chemistry. 2011; 286(1):403-9. PMID: 21030584. doi: 10.1074/jbc.M110.181016
22. Wang JC. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol. 2002; 3(6):430-40. PMID: 12042765.
23. Pommier Y, Huang SY, Gao R, Das BB, Murai J, Marchand C. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA repair. 2014; 19:114-29. doi: 10.1016/j.dnarep.2014.03.020 PMID: 24856239; PubMed Central PMCID: PMC4090310.
24. Jones SA, Hu J. Protein-primed terminal transferase activity of hepatitis B virus polymerase. J Virol. 2013; 87(5):2563-76. Epub 2012/12/21. doi: 10.1128/jvi.02786-12 PMID: 23255788; PubMed Central PMCID: PMC3571375.
25. Koniger C, Wingert I, Marsmann M, Rosler C, Beck J, Nassal M. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111 (40):E4244-53. doi: 10.1073/pnas.1409986111 PMID: 25201958; PubMed Central PMCID: PMC4209993.
26. Boregowda RK, Lin L, Zhu Q, Tian F, Hu J. Cryptic protein priming sites in two different domains of duck hepatitis B virus reverse transcriptase for initiating DNA synthesis in vitro. J Virol. 2011; 85 (15):7754-65. Epub 2011/05/20. JVI.00483-11 [pii] doi: 10.1128/JVI.00483-11 PMID: 21593164; PubMed Central PMCID: PMC3147914.
27. Wang X, Qian X, Guo HC, Hu J. Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase. J Virol. 2003; 77(8):4471-80. PMID: 12663754.
28. Lin L, Hu J. Inhibition of hepadnavirus reverse transcriptase-epsilon RNA interaction by porphyrin compounds. J Virol. 2008; 82(5):2305-12. PMID: 18094191.
29. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012; 1:e00049. doi: 10.7554/eLife.00049 PMID: 23150796; PubMed Central PMCID: PMC3485615.
30. Seeger C, Sohn JA. Targeting Hepatitis B Virus With CRISPR/Cas9. Molecular therapy Nucleic acids. 2014; 3:e216. doi: 10.1038/mtna.2014.68 PMID: 25514649; PubMed Central PMCID: PMC4272409.
31. Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother. 1997; 41(8):1715-20. PMID: 9257747
32. Gao R, Schellenberg MJ, Huang SY, Abdelmalak M, Marchand C, Nitiss KC, et al. Proteolytic degradation of topoisomerase II (Top2) enables the processing of Top2.DNA and Top2.RNA covalent complexes by tyrosyl-DNA-phosphodiesterase 2 (TDP2). The Journal of biological chemistry. 2014; 289 (26):17960-9. doi: 10.1074/jbc.M114.565374 PMID: 24808172; PubMed Central PMCID: PMC4140274.
33. Lin CP, Ban Y, Lyu YL, Liu LF. Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks. The Journal of biological chemistry. 2009; 284(41):28084-92. PMID: 19666469. doi: 10.1074/jbc.M109.030601
34. Zhang A, Lyu YL, Lin CP, Zhou N, Azarova AM, Wood LM, et al. A protease pathway for the repair of topoisomerase II-DNA covalent complexes. The Journal of biological chemistry. 2006; 281(47):35997-6003. PMID: 16973621.
35. Schellenberg MJ, Appel CD, Adhikari S, Robertson PD, Ramsden DA, Williams RS. Mechanism of repair of 5'-topoisomerase II-DNA adducts by mammalian tyrosyl-DNA phosphodiesterase2. Nature structural & molecular biology. 2012; 19(12):1363-71. doi: 10.1038/nsmb.2418 PMID: 23104055; PubMed Central PMCID: PMC3529160.
36. Shi K, Kurahashi K, Gao R, Tsutakawa SE, Tainer JA, Pommier Y, et al. Structural basis for recognition of 5'-phosphotyrosine adducts by Tdp2. Nature structural & molecular biology. 2012; 19(12):1372-7. doi: 10.1038/nsmb.2423 PMID: 23104058; PubMed Central PMCID: PMC3515695.
37. Sohn JA, Litwin S, Seeger C. Mechanism for CCC DNA synthesis in hepadnaviruses. PLoS One. 2009; 4(11):e8093. Epub 2009/12/04. doi: 10.1371/journal.pone.0008093 PMID: 19956651; PubMed Central PMCID: PMC2778999.
38. Kock J, Rosler C, Zhang JJ, Blum HE, Nassal M, Thoma C. Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner. PLoS Pathog. 2010; 6(9):e1001082. PMID: 20824087. doi: 10.1371/journal.ppat.1001082
39. Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-Cas9 system. Science. 2014; 343(6166):80-4. doi: 10.1126/science.1246981 PMID: 24336569; PubMed Central PMCID: PMC3972032.
40. Nguyen DH, Gummuluru S, Hu J. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J Virol. 2007; 81(9):4465-72. PMID: 17314171.
41. Ning X, Nguyen D, Mentzer L, Adams C, Lee H, Ashley R, et al. Secretion of genome-free hepatitis B virus-single strand blocking model for virion morphogenesis of para-retrovirus. PLoS Pathog. 2011; 7 (9):e1002255. Epub 2011/10/04. doi: 10.1371/journal.ppat.1002255 PPATHOGENS-D-11-00224 [pii]. PMID: 21966269; PubMed Central PMCID: PMC3178560.